{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:54:15Z","timestamp":1792090455683,"version":"4.4.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The universally adopted 2018 PCOS medical diagnostic and treatment guidelines for Polycystic Ovarian Syndrome (PCOS) cites the need for a brief screening measure that can be easily administered in the clinical care setting. We evaluate a 12-item questionnaire emphasizing the medical symptoms of PCOS with a group of women with PCOS as well as comparison samples of college women not diagnosed with PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>Of 120 undergraduate psychology women 18 to 41\u2009years of age, 86 screened negative on a 12-item PCOS symptoms inventory. They were compared to a group of PCOS patients diagnosed medically in a manner consistent with the Teede et al. (2018) evidence-based diagnostic guidelines. The screen-positive, screen-negative, and PCOS-confirmed groups were compared on the PCOS Quality-of-Life (QoL) questionnaire, Zung Self-Rating Depression Scale (ZDS), Spielberg State-Trait Anxiety Inventory (STAI), Fatigue Symptom Inventory (FSI), Spiritual well-being and Spiritual Beliefs Inventories, the computerized Automated Neuropsychological Assessment Metric (ANAM) battery, and an experimental tachistoscopic Bilateral Perceptual Asymmetries Letter and Dots Matching Bilateral Field Advantage (BFA) test (to evaluate the effects of early brain androgenization possible from PCOS). For each questionnaire and neuropsychological performance principal outcome, the Linear Mixed Effects (LME) model was employed to evaluate the predictive significance of demographic characteristics and group membership (confirmed cases, screen negative and screen positive cases) for these outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The PCOS-confirmed women scored more poorly than the screen-negative (reference) and screen-positive groups on all the measures of physical, emotional, social, and spiritual well-being measures. On the ANAM neuropsychological battery, PCOS-confirmed women did more poorly on Sternberg Memory and Stimulus Response throughput measures. They also had slower correct response speed for both the unilateral and bilateral dot- and letter-matching tachistoscopic stimulus presentations. However, the bilateral field advantage throughput performance ratio did not differ among groups, which is a global measure of bilateral versus unilateral brain\/behavior asymmetries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PCOS screening can be a feasible and important part of women\u2019s healthcare. PCOS-confirmed women should receive not only the medical standard of care from the 2018 guidelines, but also comprehensive psychosocial and neurocognitive support to enhance their quality of life.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12905-020-00994-8","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T08:03:18Z","timestamp":1592899398000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Exploratory study of a screening measure for polycystic ovarian syndrome, quality of life assessment, and neuropsychological evaluation"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0097-1777","authenticated-orcid":false,"given":"Michael J.","family":"Boivin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnaz","family":"Fatehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy E.","family":"Phillips-Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia R.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda N.","family":"Summers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Foley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,23]]},"reference":[{"key":"994_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/CLEP.S37559","volume":"6","author":"SM Sirmans","year":"2013","unstructured":"Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2013;6:1\u201313.","journal-title":"Clin Epidemiol"},{"issue":"12","key":"994_CR2","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.4158\/EP15748.DSCPT2","volume":"21","author":"NF Goodman","year":"2015","unstructured":"Goodman NF, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and androgen excess and Pcos society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome - part 2. Endocr Pract. 2015;21(12):1415\u201326.","journal-title":"Endocr Pract"},{"issue":"2","key":"994_CR3","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.fertnstert.2006.01.019","volume":"86","author":"F Kelestimur","year":"2006","unstructured":"Kelestimur F, et al. Prevalence of polycystic ovarian changes and polycystic ovary syndrome in premenopausal women with treated type 2 diabetes mellitus. Fertil Steril. 2006;86(2):405\u201310.","journal-title":"Fertil Steril"},{"issue":"5","key":"994_CR4","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1515\/jpem-2016-0340","volume":"30","author":"MI Hernandez","year":"2017","unstructured":"Hernandez MI, et al. Hyperandrogenism in adolescent girls: relationship with the somatotrophic axis. J Pediatr Endocrinol Metab. 2017;30(5):561\u20138.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"9","key":"994_CR5","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3109\/09513590.2010.500818","volume":"26","author":"AD Genazzani","year":"2010","unstructured":"Genazzani AD, et al. Metformin administration restores allopregnanolone response to adrenocorticotropic hormone (ACTH) stimulation in overweight hyperinsulinemic patients with PCOS. Gynecol Endocrinol. 2010;26(9):684\u20139.","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"994_CR6","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s00404-017-4623-2","volume":"297","author":"B Bottcher","year":"2018","unstructured":"Bottcher B, et al. Health-related quality of life in patients with polycystic ovary syndrome: validation of the German PCOSQ-G. Arch Gynecol Obstet. 2018;297(4):1027\u201335.","journal-title":"Arch Gynecol Obstet"},{"issue":"8","key":"994_CR7","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1093\/humrep\/dem108","volume":"22","author":"L Barnard","year":"2007","unstructured":"Barnard L, et al. Quality of life and psychological well being in polycystic ovary syndrome. Hum Reprod. 2007;22(8):2279\u201386.","journal-title":"Hum Reprod"},{"issue":"7","key":"994_CR8","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1080\/09513590.2018.1427713","volume":"34","author":"A Stapinska-Syniec","year":"2018","unstructured":"Stapinska-Syniec A, et al. Depression, sexual satisfaction, and other psychological issues in women with polycystic ovary syndrome. Gynecol Endocrinol. 2018;34(7):597\u2013600.","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"994_CR9","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.fertnstert.2011.05.072","volume":"96","author":"Y Li","year":"2011","unstructured":"Li Y, et al. Polycystic ovary syndrome is associated with negatively variable impacts on domains of health-related quality of life: evidence from a meta-analysis. Fertil Steril. 2011;96(2):452\u20138.","journal-title":"Fertil Steril"},{"issue":"2","key":"994_CR10","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/ijerph15020376","volume":"15","author":"E Rzonca","year":"2018","unstructured":"Rzonca E, et al. Determinants of Quality of Life and Satisfaction with Life in Women with Polycystic Ovary Syndrome. Int J Environ Res Public Health. 2018;15(2):376.","journal-title":"Int J Environ Res Public Health"},{"issue":"8","key":"994_CR11","first-page":"521","volume":"38","author":"M Smyka","year":"2018","unstructured":"Smyka M, Grzechocinska B, Wielgos M. The role of lifestyle changes in the treatment of polycystic ovary syndrome. Neuro Endocrinol Lett. 2018;38(8):521\u20137.","journal-title":"Neuro Endocrinol Lett"},{"key":"994_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2147\/NSS.S127475","volume":"10","author":"RC Fernandez","year":"2018","unstructured":"Fernandez RC, et al. Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies. Nat Sci Sleep. 2018;10:45\u201364.","journal-title":"Nat Sci Sleep"},{"issue":"3","key":"994_CR13","doi-asserted-by":"publisher","first-page":"zsw073","DOI":"10.1093\/sleep\/zsw073","volume":"40","author":"DA Kalmbach","year":"2017","unstructured":"Kalmbach DA, et al. Sleep Disturbance and Short Sleep as Risk Factors for Depression and Perceived Medical Errors in First-Year Residents. Sleep. 2017;40(3):zsw073.","journal-title":"Sleep"},{"key":"994_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.sleep.2016.03.014","volume":"33","author":"DA Kalmbach","year":"2017","unstructured":"Kalmbach DA, et al. Reciprocal dynamics between self-rated sleep and symptoms of depression and anxiety in young adult women: a 14-day diary study. Sleep Med. 2017;33:6\u201312.","journal-title":"Sleep Med"},{"issue":"5","key":"994_CR15","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.yhbeh.2007.02.007","volume":"51","author":"L Schattmann","year":"2007","unstructured":"Schattmann L, Sherwin BB. Testosterone levels and cognitive functioning in women with polycystic ovary syndrome and in healthy young women. Horm Behav. 2007;51(5):587\u201396.","journal-title":"Horm Behav"},{"issue":"5","key":"994_CR16","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.yhbeh.2007.02.002","volume":"51","author":"L Schattmann","year":"2007","unstructured":"Schattmann L, Sherwin BB. Effects of the pharmacologic manipulation of testosterone on cognitive functioning in women with polycystic ovary syndrome: a randomized, placebo-controlled treatment study. Horm Behav. 2007;51(5):579\u201386.","journal-title":"Horm Behav"},{"issue":"8\u201310","key":"994_CR17","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.psyneuen.2007.06.010","volume":"32","author":"L Barnard","year":"2007","unstructured":"Barnard L, et al. Cognitive functioning in polycystic ovary syndrome. Psychoneuroendocrinology. 2007;32(8\u201310):906\u201314.","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"994_CR18","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1210\/jc.2015-2318","volume":"101","author":"DA Rees","year":"2016","unstructured":"Rees DA, et al. White matter microstructure and cognitive function in young women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2016;101(1):314\u201323.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"994_CR19","first-page":"1976","volume":"83","author":"L Cronin","year":"1998","unstructured":"Cronin L, et al. Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab. 1998;83(6):1976\u201387.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"994_CR20","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","volume":"33","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602\u201318.","journal-title":"Hum Reprod"},{"issue":"3","key":"994_CR21","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","volume":"110","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2018;110(3):364\u201379.","journal-title":"Fertil Steril"},{"issue":"3","key":"994_CR22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/cen.13795","volume":"89","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Clin Endocrinol. 2018;89(3):251\u201368.","journal-title":"Clin Endocrinol"},{"issue":"5","key":"994_CR23","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.fertnstert.2013.06.043","volume":"100","author":"F Bazarganipour","year":"2013","unstructured":"Bazarganipour F, et al. Predictive factors of health-related quality of life in patients with polycystic ovary syndrome: a structural equation modeling approach. Fertil Steril. 2013;100(5):1389\u201396.","journal-title":"Fertil Steril"},{"issue":"4","key":"994_CR24","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/jsm.12405","volume":"11","author":"F Bazarganipour","year":"2014","unstructured":"Bazarganipour F, et al. Health-related quality of life in patients with polycystic ovary syndrome (PCOS): a model-based study of predictive factors. J Sex Med. 2014;11(4):1023\u201332.","journal-title":"J Sex Med"},{"key":"994_CR25","volume-title":"PCOS: the Hidden Epidemic","author":"SS Thatcher","year":"2000","unstructured":"Thatcher SS. PCOS: the Hidden Epidemic, vol. 494. Indianapolis: IN: Perspectives Press; 2000."},{"issue":"Suppl","key":"994_CR26","first-page":"72","volume":"51","author":"WW Zung","year":"1990","unstructured":"Zung WW. The role of rating scales in the identification and management of the depressed patient in the primary care setting. J Clin Psychiatry. 1990;51(Suppl):72\u20136.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"994_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12905-020-00971-1","volume":"20","author":"MJ Boivin","year":"2020","unstructured":"Boivin MJ, et al. Preliminary study on the effects of treatment for breast cancer: immunological markers as they relate to quality of life and neuropsychological performance. BMC Womens Health. 2020;20(1):109.","journal-title":"BMC Womens Health"},{"issue":"4","key":"994_CR28","first-page":"337","volume":"37","author":"WW Zung","year":"1993","unstructured":"Zung WW, Broadhead WE, Roth ME. Prevalence of depressive symptoms in primary care. J Fam Pract. 1993;37(4):337\u201344.","journal-title":"J Fam Pract"},{"issue":"1","key":"994_CR29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1207\/s15327752jpa4801_16","volume":"48","author":"CD Spielberger","year":"1984","unstructured":"Spielberger CD, Vagg PR. Psychometric properties of the STAI: a reply to Ramanaiah, Franzen, and Schill. J Pers Assess. 1984;48(1):95\u20137.","journal-title":"J Pers Assess"},{"issue":"2","key":"994_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/01674820802546204","volume":"30","author":"V Laggari","year":"2009","unstructured":"Laggari V, et al. Anxiety and depression in adolescents with polycystic ovary syndrome and Mayer-Rokitansky-Kuster-Hauser syndrome. J Psychosom Obstet Gynaecol. 2009;30(2):83\u20138.","journal-title":"J Psychosom Obstet Gynaecol"},{"issue":"5","key":"994_CR31","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/j.1365-2265.2011.04122.x","volume":"75","author":"S Livadas","year":"2011","unstructured":"Livadas S, et al. Anxiety is associated with hormonal and metabolic profile in women with polycystic ovarian syndrome. Clin Endocrinol. 2011;75(5):698\u2013703.","journal-title":"Clin Endocrinol"},{"issue":"7","key":"994_CR32","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1023\/A:1008900413113","volume":"9","author":"DM Hann","year":"2000","unstructured":"Hann DM, Denniston MM, Baker F. Measurement of fatigue in cancer patients: further validation of the fatigue symptom inventory. Qual Life Res. 2000;9(7):847\u201354.","journal-title":"Qual Life Res"},{"issue":"4","key":"994_CR33","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1023\/A:1008842517972","volume":"7","author":"DM Hann","year":"1998","unstructured":"Hann DM, et al. Measurement of fatigue in cancer patients: development and validation of the fatigue symptom inventory. Qual Life Res. 1998;7(4):301\u201310.","journal-title":"Qual Life Res"},{"issue":"3","key":"994_CR34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1046\/j.1523-5394.1998.006003143.x","volume":"6","author":"KD Stein","year":"1998","unstructured":"Stein KD, et al. A multidimensional measure of fatigue for use with cancer patients. Cancer Pract. 1998;6(3):143\u201352.","journal-title":"Cancer Pract"},{"issue":"3","key":"994_CR35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1365-2354.1995.tb00070.x","volume":"4","author":"A Bottomley","year":"1995","unstructured":"Bottomley A. The development of the Bottomley Cancer social support scale. Eur J Cancer Care (Engl). 1995;4(3):127\u201332.","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"6","key":"994_CR36","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/(SICI)1099-1611(199811\/12)7:6<460::AID-PON328>3.0.CO;2-R","volume":"7","author":"JC Holland","year":"1998","unstructured":"Holland JC, et al. A brief spiritual beliefs inventory for use in quality of life research in life-threatening illness. Psychooncology. 1998;7(6):460\u20139.","journal-title":"Psychooncology"},{"issue":"1","key":"994_CR37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/(SICI)1099-1611(199901\/02)8:1<14::AID-PON321>3.0.CO;2-E","volume":"8","author":"JC Holland","year":"1999","unstructured":"Holland JC, et al. The role of religious and spiritual beliefs in coping with malignant melanoma. Psychooncology. 1999;8(1):14\u201326.","journal-title":"Psychooncology"},{"issue":"Suppl 1","key":"994_CR38","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/j.acn.2006.10.013","volume":"22","author":"DL Reeves","year":"2007","unstructured":"Reeves DL, et al. ANAM genogram: historical perspectives, description, and current endeavors. Arch Clin Neuropsychol. 2007;22(Suppl 1):S15\u201337.","journal-title":"Arch Clin Neuropsychol"},{"issue":"Suppl 1","key":"994_CR39","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1016\/j.acn.2006.10.008","volume":"22","author":"A Cernich","year":"2007","unstructured":"Cernich A, et al. Automated neuropsychological assessment metrics sports medicine battery. Arch Clin Neuropsychol. 2007;22(Suppl 1):S101\u201314.","journal-title":"Arch Clin Neuropsychol"},{"issue":"Suppl 1","key":"994_CR40","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1016\/j.acn.2006.10.011","volume":"22","author":"T Roebuck-Spencer","year":"2007","unstructured":"Roebuck-Spencer T, et al. Assessing change with the automated neuropsychological assessment metrics (ANAM): issues and challenges. Arch Clin Neuropsychol. 2007;22(Suppl 1):S79\u201387.","journal-title":"Arch Clin Neuropsychol"},{"issue":"1","key":"994_CR41","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0010-9452(96)80022-0","volume":"32","author":"TE Ludwig","year":"1996","unstructured":"Ludwig TE, Jeeves MA. Maximizing the bilateral field advantage on verbal and nonverbal matching tasks. Cortex. 1996;32(1):131\u201341.","journal-title":"Cortex"},{"issue":"4","key":"994_CR42","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S0010-9452(13)80291-2","volume":"29","author":"TE Ludwig","year":"1993","unstructured":"Ludwig TE, et al. The bilateral field advantage on a letter-matching task. Cortex. 1993;29(4):691\u2013713.","journal-title":"Cortex"},{"issue":"2","key":"994_CR43","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1177\/009164719602400206","volume":"24","author":"CA Ash","year":"1996","unstructured":"Ash CA, et al. Unilateral and bilateral brain hemispheric advantage on visual matching tasks and their relationship to styles of religiosity. J Psychol Theol. 1996;24(2):133\u201354.","journal-title":"J Psychol Theol"},{"issue":"10","key":"994_CR44","first-page":"YE01","volume":"10","author":"MA Bujang","year":"2016","unstructured":"Bujang MA, Adnan TH. Requirements for minimum sample size for sensitivity and specificity analysis. J Clin Diagn Res. 2016;10(10):YE01\u20136.","journal-title":"J Clin Diagn Res"},{"issue":"1","key":"994_CR45","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/cen.13858","volume":"90","author":"M Amiri","year":"2019","unstructured":"Amiri M, et al. The relationship between clinical and biochemical characteristics and quality of life in patients with polycystic ovary syndrome. Clin Endocrinol. 2019;90(1):129\u201337.","journal-title":"Clin Endocrinol"},{"issue":"11","key":"994_CR46","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11920-017-0834-2","volume":"19","author":"LG Cooney","year":"2017","unstructured":"Cooney LG, Dokras A. Depression and anxiety in polycystic ovary syndrome: etiology and treatment. Curr Psychiatry Rep. 2017;19(11):83.","journal-title":"Curr Psychiatry Rep"},{"issue":"5","key":"994_CR47","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/humrep\/dex044","volume":"32","author":"LG Cooney","year":"2017","unstructured":"Cooney LG, et al. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2017;32(5):1075\u201391.","journal-title":"Hum Reprod"},{"issue":"2","key":"994_CR48","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4274\/npa.y6778","volume":"51","author":"BB Annagur","year":"2014","unstructured":"Annagur BB, Tazegul A, Akbaba N. Body image, self-esteem and depressive symptomatology in women with polycystic ovary syndrome. Noro Psikiyatr Ars. 2014;51(2):129\u201332.","journal-title":"Noro Psikiyatr Ars"},{"issue":"10","key":"994_CR49","first-page":"829","volume":"11","author":"F Bazarganipour","year":"2013","unstructured":"Bazarganipour F, et al. Body image satisfaction and self-esteem status among the patients with polycystic ovary syndrome. Iran J Reprod Med. 2013;11(10):829\u201336.","journal-title":"Iran J Reprod Med"},{"issue":"5","key":"994_CR50","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/09513590312331290268","volume":"17","author":"S Coffey","year":"2003","unstructured":"Coffey S, Mason H. The effect of polycystic ovary syndrome on health-related quality of life. Gynecol Endocrinol. 2003;17(5):379\u201386.","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"994_CR51","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jpag.2013.04.005","volume":"26","author":"G Ghazeeri","year":"2013","unstructured":"Ghazeeri G, et al. Anxiety, cognitive, and depressive assessment in adolescents with polycystic ovarian syndrome: a pilot study. J Pediatr Adolesc Gynecol. 2013;26(5):269\u201373.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"5","key":"994_CR52","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.fertnstert.2016.01.034","volume":"105","author":"RS Soleman","year":"2016","unstructured":"Soleman RS, et al. Does polycystic ovary syndrome affect cognition? A functional magnetic resonance imaging study exploring working memory. Fertil Steril. 2016;105(5):1314\u201321 e1.","journal-title":"Fertil Steril"},{"issue":"2","key":"994_CR53","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41443-017-0006-2","volume":"30","author":"F Nasiri Amiri","year":"2018","unstructured":"Nasiri Amiri F, et al. Sexual function in women with polycystic ovary syndrome and their hormonal and clinical correlations. Int J Impot Res. 2018;30(2):54\u201361.","journal-title":"Int J Impot Res"},{"issue":"2","key":"994_CR54","doi-asserted-by":"publisher","first-page":"e13612","DOI":"10.5812\/ijem.13612","volume":"12","author":"F Nasiri Amiri","year":"2014","unstructured":"Nasiri Amiri F, et al. The experience of women affected by polycystic ovary syndrome: a qualitative study from Iran. Int J Endocrinol Metab. 2014;12(2):e13612.","journal-title":"Int J Endocrinol Metab"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-020-00994-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-020-00994-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-020-00994-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T22:03:22Z","timestamp":1650405802000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-020-00994-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,23]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["994"],"URL":"https:\/\/doi.org\/10.1186\/s12905-020-00994-8","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,23]]},"assertion":[{"value":"7 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consent was obtained from each of the study participants before conducting any one-to-one interview. All responses given by participants were anonymous and we ensured confidentiality of the data collected. We also obtained approval from Indiana Wesleyan University, Research and Ethics committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}